Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0001728746-26-000008

Chief Scientific Officer sold 51,707 shares at an average $28.40 ($1,468,251)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lillie James Woodruff Chief Scientific Officer 2026-05-04 Sale 10b5-1 −9,250 $27.50 $254,375 285,907 D
Lillie James Woodruff Chief Scientific Officer 2026-05-04 Sale 10b5-1 −5,526 $28.37 $156,773 280,381 D
Lillie James Woodruff Chief Scientific Officer 2026-05-04 Sale 10b5-1 −320 $29.56 $9,459 280,061 D
Lillie James Woodruff Chief Scientific Officer 2026-05-04 Sale 10b5-1 −705 $30.08 $21,206 279,356 D
Lillie James Woodruff Chief Scientific Officer 2026-05-05 Sale 10b5-1 −10,132 $28.12 $284,912 269,224 D
Lillie James Woodruff Chief Scientific Officer 2026-05-05 Sale 10b5-1 −963 $29.00 $27,927 268,261 D
Lillie James Woodruff Chief Scientific Officer 2026-05-06 Sale 10b5-1 −8,390 $28.04 $235,256 259,871 D
Lillie James Woodruff Chief Scientific Officer 2026-05-06 Sale 10b5-1 −16,421 $29.13 $478,344 243,450 D
Open-market sales · 51,707 sh · avg $28.40 · $1,468,251
Loading xslF345X06/form4-05062026_080505.xml…